Risk of postoperative complications among ulcerative colitis patients treated preoperatively with vedolizumab: a matched case-control study

BACKGROUND: Although biologic agents have revolutionized the medical management of severe ulcerative colitis (UC), there is considerable controversy regarding adverse effects of vedolizumab on surgical outcomes. We evaluated 30-day postoperative morbidity in UC patients undergoing abdominal colectom...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jeong Yeon, Zaghiyan, Karen, Lightner, Amy, Fleshner, Phillip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059353/
https://www.ncbi.nlm.nih.gov/pubmed/32138717
http://dx.doi.org/10.1186/s12893-020-00698-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059353/
https://www.ncbi.nlm.nih.gov/pubmed/32138717
http://dx.doi.org/10.1186/s12893-020-00698-8

Ejemplares similares